Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06268886
Other study ID # CN008-0003
Secondary ID 2023-504840-32-0
Status Recruiting
Phase Phase 2
First received
Last updated
Start date March 20, 2024
Est. completion date November 16, 2027

Study information

Verified date April 2024
Source Bristol-Myers Squibb
Contact BMS Study Connect Contact Center www.BMSStudyConnect.com
Phone 855-907-3286
Email Clinical.Trials@bms.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants with Early Alzheimer's Disease.


Recruitment information / eligibility

Status Recruiting
Enrollment 475
Est. completion date November 16, 2027
Est. primary completion date August 31, 2027
Accepts healthy volunteers No
Gender All
Age group 50 Years to 80 Years
Eligibility Inclusion Criteria - Mild cognitive impairment (MCI) due to Alzheimer's disease (AD) or mild AD dementia consistent with the National Institute on Aging and the Alzheimer's Association (NIA-AA) core clinical criteria. - Global Clinical Dementia Rating (CDR) score of 0.5 to 1.0 and a CDR-Memory Box score of 0.5 and greater at screening and Baseline. - Evidence of AD pathology. - Objective impairment in episodic memory as indicated by at least 1 standard deviation below age-adjusted mean in the Wechsler Memory Scale IV-Logical Memory Subtest II (WMS-IV LM II). - Mini Mental Status Examination (MMSE) score = 22 to 30 (inclusive). Exclusion Criteria - Any evidence of a condition that may affect cognition other than AD. - Contraindications to PET imaging. - Inability to tolerate or contraindication to magnetic resonance imaging. - Any serious medical condition that could, in the opinion of the investigator, affect the participant's safety or interfere with study assessments. - Geriatric Depression Scale (GDS) score greater than or equal to 8 at screening. - Other protocol-defined Inclusion/Exclusion criteria apply.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
BMS-986446
Specified dose on specified days
Other:
Placebo
Specified dose on specified days

Locations

Country Name City State
Australia Local Institution - 0115 Carlton North Victoria
Australia Local Institution - 0002 Darlinghurst New South Wales
Australia Local Institution - 0111 East Gosford New South Wales
Australia Local Institution - 0093 Heidelberg Victoria
Australia Local Institution - 0170 Macquarie Park New South Wales
Australia Local Institution - 0001 Malvern Victoria
Australia Local Institution - 0125 Melbourne Victoria
Australia Local Institution - 0094 Nedlands Western Australia
Australia Local Institution - 0147 Parkville Victoria
Australia Local Institution - 0116 Southport Queensland
Belgium Local Institution - 0122 Anderlecht Brussels
Belgium Local Institution - 0175 Antwerpen Brussel
Belgium Local Institution - 0074 Brussel BRU
Belgium Local Institution - 0097 Brussels
Belgium Local Institution - 0082 Kortrijk VWV
Belgium Local Institution - 0076 Leuven
Belgium Local Institution - 0078 Liege WLG
Canada Local Institution - 0113 Greenfield Park Quebec
Canada Local Institution - 0064 Kelowna British Columbia
Canada Local Institution - 0030 Montreal Quebec
Canada Local Institution - 0075 Montreal Quebec
Canada Local Institution - 0112 Ottawa Ontario
Canada Local Institution - 0162 Peterborough Ontario
Canada Local Institution - 0053 Quebec
Canada Local Institution - 0044 Toronto Ontario
Canada Local Institution - 0047 Toronto Ontario
Canada Local Institution - 0109 Toronto Ontario
Canada Local Institution - 0049 West Vancouver British Columbia
Denmark Local Institution - 0072 Aarhus N Aarhus
Denmark Local Institution - 0085 Copenhagen
Denmark Local Institution - 0166 Esbjerg
France Local Institution - 0108 Angers
France Local Institution - 0066 Limoges cedex
France Local Institution - 0086 Nantes
France Local Institution - 0067 Paris
France Local Institution - 0084 Rouen
France Local Institution - 0131 Toulouse
France Local Institution - 0088 Villeurbanne
Japan Local Institution - 0185 Bunkyo-Ku
Japan Local Institution - 0188 Kasukabe-Shi
Japan Local Institution - 0179 Kodaira-Shi
Japan Local Institution - 0186 Kurashiki-Shi
Japan Local Institution - 0180 Nagoya-Shi
Japan Local Institution - 0181 Nagoya-Shi
Japan Local Institution - 0178 Osaka-shi
Japan Local Institution - 0184 Setagaya-Ku
Korea, Republic of Local Institution - 0110 Gwangjingu
Korea, Republic of Local Institution - 0050 Incheon
Korea, Republic of Local Institution - 0114 Junggu
Korea, Republic of Local Institution - 0117 Songpa-gu Seoul
Netherlands Local Institution - 0099 's Hertogenbosch
Netherlands Local Institution - 0124 Amsterdam NH
Netherlands Local Institution - 0126 Breda North Brabant
Netherlands Local Institution - 0165 Haarlem NH
Netherlands Local Institution - 0177 Zwolle OV
Poland Local Institution - 0083 Poznan
Poland Local Institution - 0079 Pruszkow MZ
Poland Local Institution - 0007 Szczecin
Poland Local Institution - 0055 Warszawa MZ
Singapore Local Institution - 0091 Singapore
Spain Local Institution - 0036 Barcelona B
Spain Local Institution - 0096 Barcelona
Spain Local Institution - 0158 Barcelona B
Spain Local Institution - 0171 Barcelona
Spain Local Institution - 0172 Barcelona
Spain Local Institution - 0063 Madrid M
Spain Local Institution - 0006 Pamplona
Spain Local Institution - 0010 Pozuelo De Alarcon M
Spain Local Institution - 0054 Sant Cugat Del Vallès CT
Spain Local Institution - 0004 Sevilla
Sweden Local Institution - 0160 Huddinge
Sweden Local Institution - 0167 Malmo M
Sweden Local Institution - 0138 Uppsala Uppsala Lan
Sweden Local Institution - 0173 Uppsala
United Kingdom Local Institution - 0127 Bristol
United Kingdom Local Institution - 0121 Enfield LND
United Kingdom Local Institution - 0090 Guildford SRY
United Kingdom Local Institution - 0089 Leatherhead SRY
United Kingdom Local Institution - 0070 London LND
United Kingdom Local Institution - 0100 London LND
United Kingdom Local Institution - 0103 Winchester HAM
United States Abington Neurological Associates (ANA) Abington Pennsylvania
United States Neurological Associates of Albany, P.C. Albany New York
United States Neurology of Central Florida Altamonte Springs Florida
United States Local Institution - 0157 Amherst New York
United States JEM Research Institute Atlantis Florida
United States Senior Adults Specialty Research Austin Texas
United States Local Institution - 0155 Beachwood Ohio
United States Gadolin Research Beaumont Texas
United States Boston Clinical Trials Boston Massachusetts
United States Boston Neuropsychiatry Braintree Massachusetts
United States MD First Research - Chandler Chandler Arizona
United States Great Lakes Clinical Trials Chicago Illinois
United States Local Institution - 0020 Clermont Florida
United States Columbus Memory Center Columbus Georgia
United States Neurology Clinic, P.C. - Germantown Park Location Cordova Tennessee
United States Kerwin Research Center and Memory Care Dallas Texas
United States Neurology Consultants of Dallas Dallas Texas
United States Associated Neurologists, P.C. - Danbury Office Danbury Connecticut
United States Arrow Clinical Trials Daytona Beach Florida
United States Rhode Island Mood & Memory Research Institute East Providence Rhode Island
United States Local Institution - 0161 Elk Grove Village Illinois
United States Local Institution - 0164 Encino California
United States Rocky Mountain Movement Disorder Center Englewood Colorado
United States Local Institution - 0140 Franklin Tennessee
United States Local Institution - 0139 Fullerton California
United States Gilbert Neurology Gilbert Arizona
United States Local Institution - 0059 Greenacres City Florida
United States Great Lakes Clinical Trials d/b/a Flourish Research Gurnee Gurnee Illinois
United States Baylor College of Medicine Houston Texas
United States Memorial Neurological Association - Main Office Houston Texas
United States Local Institution - 0187 Jacksonville Florida
United States Local Institution - 0152 La Jolla California
United States Charter Research - Lady Lake Lady Lake Florida
United States Local Institution - 0146 Lakeland Florida
United States Local Institution - 0183 Lakewood California
United States Local Institution - 0073 Lomita California
United States Local Institution - 0142 Los Alamitos California
United States Local Institution - 0065 Madison Wisconsin
United States Local Institution - 0143 Maitland Florida
United States The Feinstein Institute for Medical Research Manhasset New York
United States Alzheimer's Memory Center Matthews North Carolina
United States Merritt Island Medical Research Merritt Island Florida
United States ActivMed Practices & Research, Inc. - Methuen Methuen Massachusetts
United States Advance Medical Research Center Miami Florida
United States Hope Research Network, LLC Miami Florida
United States IMIC Research Miami Florida
United States Local Institution - 0156 Miami Florida
United States Local Institution - 0176 Miami Florida
United States Miami Jewish Health Systems Miami Florida
United States Optimus U, Inc. Miami Florida
United States Premier Clinical Research Institute - Miami Miami Florida
United States Project 4 Research Miami Florida
United States Vitae Research Center Miami Florida
United States Neurovations Napa California
United States Hasbani Neurology New Haven Connecticut
United States Local Institution - 0148 New Haven Connecticut
United States Neurological Associates of Long Island New Hyde Park New York
United States Suncoast Clinical Research New Port Richey Florida
United States Columbia University Medical Center - The Neurological Institute of New York New York New York
United States Icahn School of Medicine at Mount Sinai (ISMMS) - Alzheimer's Disease Research Center New York New York
United States Local Institution - 0095 New York New York
United States Boston Center for Memory Newton Massachusetts
United States Local Institution - 0144 Ocala Florida
United States Headlands Research - Orlando Orlando Florida
United States Local Institution - 0150 Ozark Missouri
United States Local Institution - 0141 Palm Beach Gardens Florida
United States Local Institution - 0145 Park Ridge Illinois
United States Hospital of the University of Pennsylvania Philadelphia Pennsylvania
United States Xenoscience Inc. - 21st Century Neurology Phoenix Arizona
United States Office of Donald S. Marks, M.D., P.C. Plymouth Massachusetts
United States Keystone Clinical Studies, LLC Plymouth Meeting Pennsylvania
United States ActivMed Practices & Research, Inc. - Portsmouth Portsmouth New Hampshire
United States Princeton Medical Institute Princeton New Jersey
United States Local Institution - 0163 Providence Rhode Island
United States Rhode Island Hospital - Alzheimer's Disease and Memory Disorders Center Providence Rhode Island
United States Local Institution - 0168 Richmond Virginia
United States Be Well MD Round Rock Texas
United States Central Texas Neurology Consultants (CTNC) Round Rock Texas
United States Local Institution - 0169 Saint Louis Missouri
United States UCSF Medical Center- Mission Bay San Francisco California
United States Local Institution - 0137 Santa Ana California
United States Imaging Endpoints LLC Scottsdale Arizona
United States Office of Allan M. Block, MD Scottsdale Arizona
United States Local Institution - 0135 Seal Beach California
United States California Neuroscience Research Medical Group, Inc (CNR) Sherman Oaks California
United States Southern Illinois University School of Medicine - SIU Neurology Clinic Springfield Illinois
United States Local Institution - 0153 Stamford Connecticut
United States Alzheimer's Research and Treatment Center Stuart Stuart Florida
United States Local Institution - 0136 Stuart Florida
United States Baycare Clinical Research, LLC Tampa Florida
United States First Choice Neurology - Tampa Neurology Associates Tampa Florida
United States Johnnie B. Byrd, Sr. Alzheimer's Foundation, Inc Tampa Florida
United States Advanced Memory Research Institute of NJ Toms River New Jersey
United States Center for Neurosciences - Tucson Tucson Arizona
United States The Banner Alzheimer's Institute - Tucson Tucson Arizona
United States Tucson Neuroscience Research, LLC Tucson Arizona
United States Adams Clinical Trials, LLC Watertown Massachusetts
United States Alzheimer's Research and Treatment Center - Wellington Location Wellington Florida
United States Neurology Specialists of Monmouth County, PA West Long Branch New Jersey
United States Local Institution - 0149 West Palm Beach Florida
United States Waypoint Research LLC Windermere Florida
United States Charter Research - Winter Park Winter Park Florida
United States Conquest Research LLC Winter Park Florida

Sponsors (1)

Lead Sponsor Collaborator
Bristol-Myers Squibb

Countries where clinical trial is conducted

United States,  Australia,  Belgium,  Canada,  Denmark,  France,  Japan,  Korea, Republic of,  Netherlands,  Poland,  Singapore,  Spain,  Sweden,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean change from baseline in Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score At week 76
Secondary Mean change from baseline in brain tau deposition as measured by tau positron emission tomography (PET) At week 76
Secondary Mean change from baseline in integrated Alzheimer's Disease Rating Scale (iADRS) score At week 76
Secondary Mean change from baseline in Alzheimer's Disease Assessment Scale-Cognitive subscale (ADASCog14) score At week 76
Secondary Mean change from baseline in Alzheimer's Disease Cooperative Study-instrumental Activities of Daily Living scale (ADCS-iADL) score At week 76
Secondary Mean change from baseline in Mini Mental State Examination (MMSE) score At week 76
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03625401 - Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease Phase 2
Recruiting NCT05983575 - A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's Disease Phase 3
Completed NCT05989087 - The Resting-state EEG Gamma Oscillations in Alzheimer's Disease
Recruiting NCT06080659 - Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity N/A
Not yet recruiting NCT06099587 - MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease N/A
Not yet recruiting NCT05604183 - Hyperspectral Retinal Observations for the Cross-sectional Detection of Alzheimer's Disease N/A
Withdrawn NCT03514875 - Effects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) Patients N/A
Recruiting NCT06203106 - NYSCF Scientific Discovery Biobank
Completed NCT03706885 - Efavirenz for Patients With Alzheimer's Disease Phase 1
Active, not recruiting NCT03661034 - Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study) N/A
Not yet recruiting NCT05006599 - SNIFF - 3-Week Aptar CPS Device Phase 2
Recruiting NCT02740634 - Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study N/A
Active, not recruiting NCT03069391 - The Interactive Physical and Cognitive Exercise System N/A
Recruiting NCT04701957 - The Ketogenic Diet for Alzheimer's Disease N/A
Recruiting NCT04100889 - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
Recruiting NCT04656860 - Juice Plus Supplement Clinical Trial N/A
Recruiting NCT05315895 - The Dampness Syndrome of Chinese Medicine Cohort Study
Recruiting NCT04916964 - Adapted Home-based Exercise Program "T&E" (Test-and-Exercise) in Persons With Alzheimer's Disease (HOPE Trial) N/A
Recruiting NCT04804618 - Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease
Recruiting NCT04680013 - Genetic Studies in Familial Dementia